Key result
Higher lymphocyte-to-CRP ratio linked to ~36% lower risk of coronary artery disease.
Why the study?
The relationship between the lymphocyte-to-C-reactive protein ratio (LCR) and coronary artery disease development and severity was unclear.
Is the lymphocyte-to-C-reactive protein ratio (LCR) associated with the development and severity of coronary artery disease?
Observational (n=1,107)
No
Is the lymphocyte-to-C-reactive protein ratio (LCR) associated with the development and severity of coronary artery disease?
Effect estimate: OR 0.635 (95% CI 0.477-0.845)
p-value: p=0.002
A higher lymphocyte-to-C-reactive protein ratio (LCR) is independently associated with a lower risk of developing coronary artery disease and less severe coronary stenosis.
Coronary atherosclerosis is a chronic systemic inflammatory disease. Laboratory parameters such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and systemic immune inflammation index (SII) have been used to assess inflammation degree and coronary artery disease (CAD) severity. The lymphocyte-to-C-reactive protein ratio (LCR) is a new SII. However, its relationship with CAD development and severity is unclear. A total of 1,107 patients (479 in control group, 628 in CAD group) underwent coronary angiography. The routine and biochemical indices of the venous blood of patients were assessed before coronary angiography. LCR, SII, NLR and PLR were calculated and statistical analyses were performed. Propensity score matching (PSM) and a logistic regression model were used to analyze the relationship between LCR and CAD. After the PSM, 384 pairs of patients with or without CAD were successfully matched. After the median binary classification of all indicators, uni- and multivariate logistic regression analyses showed that platelet count was an independent risk factor and LCR was an independent protective factor. Using the same method, in the coronary heart disease severity group, 212 pairs were successfully matched and NLR and PLR were independent risk factors, while LCR was an independent protective factor. In conclusion, LCR is an independent protective factor against CAD development and severity.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2023) conducted an observational in Coronary artery disease (n=1,107). Lymphocyte-to-C-reactive protein ratio (LCR) vs. Control group (without CAD) was evaluated on Presence of coronary artery disease (OR 0.635, 95% CI 0.477-0.845, p=0.002). The lymphocyte-to-C-reactive protein ratio (LCR) was identified as an independent protective factor against the development of coronary artery disease (OR 0.635).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: